Cost-efficacy of Atraumatic Restorations (ART) Using Different Encapsulated Glass Ionomer Cement
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT02730000 |
Recruitment Status :
Completed
First Posted : April 6, 2016
Last Update Posted : November 7, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Dental Caries | Procedure: ART with Equia Procedure: ART with Riva Self Cure | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 148 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | Single (Outcomes Assessor) |
Primary Purpose: | Treatment |
Official Title: | Cost-efficacy of Atraumatic Restorations (ART) Using Different Encapsulated Glass Ionomer Cement |
Study Start Date : | July 2016 |
Actual Primary Completion Date : | November 2018 |
Actual Study Completion Date : | November 2018 |
Arm | Intervention/treatment |
---|---|
Active Comparator: ART with Equia
Occlusal-proximal restoration in primary molars using Equia (Easy/Quick/Unique/Intelligent/Aesthetic) from GC Corp, encapsulated, pre-dosed and mechanized handling.
|
Procedure: ART with Equia
Occlusal-proximal ART restorations in primary molars using Equia (Easy/Quick/Unique/ Intelligent/Aesthetic) will be performed. No local anesthesia will be used. Infected carious tissue will be removed with hand instruments, and the cavities restored with GIC (Glass Ionomer Cement). The cavity will be filled with GIC. After the press-finger technique, the excess of material will be removed and occlusion will be checked. |
Experimental: ART with Riva Self Cure
Occlusal-proximal restoration in primary molars using Riva Self Cure from SDI, encapsulated, pre-dosed and mechanized handling.
|
Procedure: ART with Riva Self Cure
Occlusal-proximal ART restorations in primary molars using Riva Self Cure will be performed. No local anesthesia will be used. Infected carious tissue will be removed with hand instruments, and the cavities restored with GIC (Glass Ionomer Cement). The cavity will be filled with GIC. After the press-finger technique, the excess of material will be removed and occlusion will be checked. |
- Longevity of atraumatic restoration [ Time Frame: up to 24 months ]The treatments will be classified as successful when they present a clinical satisfactory aspect. Otherwise, "minor failure" will be analyzed. "Minor failures" are those in which there is a defect in the restoration/crown, but it does not interfere with the tooth health.
- Cost-efficacy assessment [ Time Frame: an average of 24 months ]Treatment costs will be calculated considering professional costs and procedure costs. In order to calculate the professional cost the time spent in each session will be converted in hours and multiplied by the medium income of the dentist per hour as related by the Brazilian Ministry of Labour and Employment ($36,23). On the other hand, to estimate the procedure cost, it will be considered both variable cost, which includes electricity and equipment depreciation, and materials cost. To calculate the equipment depreciation (peripherals, dental chair and instrumental), the investigators will consider their price, the lifespan of five years and a monthly use of 160 hours, using an estimate value per hour of $1,81. All materials used in each procedure will have their specifications and quantity registered. Prices will be inferences from the market value converted in US Dollars and obtained by the medium of the values from different places that commercialized the referred products.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 4 Years to 8 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Children aging between 4 and 8 years
- presenting good health conditions
- whose parents or legal guardians accept and sign the consent form
- with at least one occlusal proximal caries lesion in primary molars
- only occlusal-proximal surfaces with caries lesions with dentin involvement
Exclusion Criteria:
- severe behavioral issues
- presence of fistula or abscess near the selected tooth
- presence of pulp exposure in the selected tooth
- presence of mobility in the selected tooth

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT02730000
Brazil | |
University of Sao Paulo | |
Sao Paulo, Brazil, 05508-000 |
Principal Investigator: | Daniela P Raggio, Professor | University of Sao Paulo |
Responsible Party: | Daniela Prócida Raggio, Associated Professor, University of Sao Paulo |
ClinicalTrials.gov Identifier: | NCT02730000 |
Other Study ID Numbers: |
RIVAART |
First Posted: | April 6, 2016 Key Record Dates |
Last Update Posted: | November 7, 2018 |
Last Verified: | November 2018 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | No |
Dental Atraumatic Restorative Treatment Primary Teeth Clinical Efficacy Cost Analysis Glass Ionomer Cement |
Dental Caries Tooth Demineralization Tooth Diseases Stomatognathic Diseases |